MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation - PubMed (original) (raw)
. 2005 Apr 22;280(16):16163-9.
doi: 10.1074/jbc.M412713200. Epub 2005 Feb 17.
Affiliations
- PMID: 15722361
- DOI: 10.1074/jbc.M412713200
Free article
MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation
Michael S Kim et al. J Biol Chem. 2005.
Free article
Abstract
Human osteoclast formation from monocyte precursors under the action of receptor activator of nuclear factor-kappaB ligand (RANKL) was suppressed by granulocyte macrophage colony-stimulating factor (GM-CSF), with down-regulation of critical osteoclast-related nuclear factors. GM-CSF in the presence of RANKL and macrophage colony-stimulating factor resulted in mononuclear cells that were negative for tartrate-resistant acid phosphatase (TRAP) and negative for bone resorption. CD1a, a dendritic cell marker, was expressed in GM-CSF, RANKL, and macrophage colony-stimulating factor-treated cells and absent in osteoclasts. Microarray showed that the CC chemokine, monocyte chemotactic protein 1 (MCP-1), was profoundly repressed by GM-CSF. Addition of MCP-1 reversed GM-CSF suppression of osteoclast formation, recovering the bone resorption phenotype. MCP-1 and chemokine RANTES (regulated on activation normal T cell expressed and secreted) permitted formation of TRAP-positive multinuclear cells in the absence of RANKL. However, these cells were negative for bone resorption. In the presence of RANKL, MCP-1 significantly increased the number of TRAP-positive multinuclear bone-resorbing osteoclasts (p = 0.008). When RANKL signaling through NFATc1 was blocked with cyclosporin A, both MCP-1 and RANTES expression was down-regulated. Furthermore, addition of MCP-1 and RANTES reversed the effects of cyclosporin A and recovered the TRAP-positive multinuclear cell phenotype. Our model suggests that RANKL-induced chemokines are involved in osteoclast differentiation at the stage of multinucleation of osteoclast precursors and provides a rationale for increased osteoclast activity in inflammatory conditions where chemokines are abundant.
Similar articles
- MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
Kim MS, Day CJ, Selinger CI, Magno CL, Stephens SR, Morrison NA. Kim MS, et al. J Biol Chem. 2006 Jan 13;281(2):1274-85. doi: 10.1074/jbc.M510156200. Epub 2005 Nov 8. J Biol Chem. 2006. PMID: 16280328 - Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG, Sugiyama E, Shinoda K, Hounoki H, Taki H, Maruyama M, Miyahara T, Kobayashi M. Kamel Mohamed SG, et al. Biochem Biophys Res Commun. 2005 Apr 15;329(3):839-45. doi: 10.1016/j.bbrc.2005.02.049. Biochem Biophys Res Commun. 2005. PMID: 15752732 - Epigenetic and transcriptional regulation of osteoclast differentiation.
Kurotaki D, Yoshida H, Tamura T. Kurotaki D, et al. Bone. 2020 Sep;138:115471. doi: 10.1016/j.bone.2020.115471. Epub 2020 Jun 8. Bone. 2020. PMID: 32526404 Review. - The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications.
Bordukalo-Nikšić T, Kufner V, Vukičević S. Bordukalo-Nikšić T, et al. Front Immunol. 2022 Apr 26;13:869422. doi: 10.3389/fimmu.2022.869422. eCollection 2022. Front Immunol. 2022. PMID: 35558080 Free PMC article. Review.
Cited by
- Comparative Study of the Cytokine Profiles of Serum and Tissues from Patients with the Ossification of the Posterior Longitudinal Ligament.
Fay LY, Kuo CH, Chang HK, Yeh MY, Chang CC, Ko CC, Tu TH, Kuo YH, Hsu WY, Hung CH, Chen CJ, Wu JC, Tsai MJ, Huang WC, Cheng H, Lee MJ. Fay LY, et al. Biomedicines. 2023 Jul 18;11(7):2021. doi: 10.3390/biomedicines11072021. Biomedicines. 2023. PMID: 37509659 Free PMC article. - Senescent mesenchymal stem/stromal cells in pre-metastatic bone marrow of untreated advanced breast cancer patients.
Borzone FR, Giorello MB, Martinez LM, Sanmartin MC, Feldman L, Dimase F, Batagelj E, Yannarelli G, Chasseing NA. Borzone FR, et al. Oncol Res. 2023 May 24;31(3):361-374. doi: 10.32604/or.2023.028104. eCollection 2023. Oncol Res. 2023. PMID: 37305388 Free PMC article. - Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.
Fonseca Ó, Gomes MS, Amorim MA, Gomes AC. Fonseca Ó, et al. Biomolecules. 2023 Feb 24;13(3):425. doi: 10.3390/biom13030425. Biomolecules. 2023. PMID: 36979360 Free PMC article. Review. - Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients.
Fernández Vallone V, Borzone FR, Martinez LM, Giorello MB, Choi H, Dimase F, Feldman L, Bordenave RH, Chudzinski-Tavassi AM, Batagelj E, Chasseing NA. Fernández Vallone V, et al. Front Oncol. 2023 Feb 20;13:1073793. doi: 10.3389/fonc.2023.1073793. eCollection 2023. Front Oncol. 2023. PMID: 36890825 Free PMC article. - Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability.
Nasiri-Ansari N, Spilioti E, Kyrou I, Kalotychou V, Chatzigeorgiou A, Sanoudou D, Dahlman-Wright K, Randeva HS, Papavassiliou AG, Moutsatsou P, Kassi E. Nasiri-Ansari N, et al. Int J Mol Sci. 2022 Sep 19;23(18):10960. doi: 10.3390/ijms231810960. Int J Mol Sci. 2022. PMID: 36142876 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous